OBJECTIVE: Previous studies of cognitive therapy (CT) for depression have examined therapist adherence and the therapeutic alliance as predictors of subsequent symptom change. However, little is known about these CT process variables when CT is delivered in combination with antidepressant medication. METHOD: In a sample of 176 depressed outpatients randomized to the combined condition of a clinical trial, we examined ratings of adherence and alliance as predictors of subsequent session-to-session symptom change across early CT sessions. RESULTS: Both adherence to Behavioral Methods/Homework and the therapeutic alliance significantly predicted session-to-session symptom change. In models in which patients' medication regimen and prior symptom change were covaried, only Behavioral Methods/Homework remained a significant predictor of subsequent symptom change. CONCLUSIONS: Our findings highlight the utility of Behavioral Methods/Homework in combined treatment for promoting early session-to-session symptom change. (PsycINFO Database Record (c) 2012 APA, all rights reserved).
RCT Entities:
OBJECTIVE: Previous studies of cognitive therapy (CT) for depression have examined therapist adherence and the therapeutic alliance as predictors of subsequent symptom change. However, little is known about these CT process variables when CT is delivered in combination with antidepressant medication. METHOD: In a sample of 176 depressed outpatients randomized to the combined condition of a clinical trial, we examined ratings of adherence and alliance as predictors of subsequent session-to-session symptom change across early CT sessions. RESULTS: Both adherence to Behavioral Methods/Homework and the therapeutic alliance significantly predicted session-to-session symptom change. In models in which patients' medication regimen and prior symptom change were covaried, only Behavioral Methods/Homework remained a significant predictor of subsequent symptom change. CONCLUSIONS: Our findings highlight the utility of Behavioral Methods/Homework in combined treatment for promoting early session-to-session symptom change. (PsycINFO Database Record (c) 2012 APA, all rights reserved).
Authors: M B Keller; J P McCullough; D N Klein; B Arnow; D L Dunner; A J Gelenberg; J C Markowitz; C B Nemeroff; J M Russell; M E Thase; M H Trivedi; J Zajecka Journal: N Engl J Med Date: 2000-05-18 Impact factor: 91.245
Authors: Mark Olfson; Steven C Marcus; Benjamin Druss; Lynn Elinson; Terri Tanielian; Harold Alan Pincus Journal: JAMA Date: 2002-01-09 Impact factor: 56.272
Authors: D R Strunk; M O Stewart; S D Hollon; R J DeRubeis; J Fawcett; J D Amsterdam; R C Shelton Journal: Psychol Med Date: 2009-11-06 Impact factor: 7.723
Authors: Marlissa C Amole; Jill M Cyranowski; Laren R Conklin; John C Markowitz; Stacy E Martin; Holly A Swartz Journal: J Psychother Integr Date: 2016-06-06
Authors: Shannon Wiltsey Stirman; Kristin Pontoski; Torrey Creed; Regina Xhezo; Arthur C Evans; Aaron T Beck; Paul Crits-Christoph Journal: Adm Policy Ment Health Date: 2017-01